[{"Assets_0_FY_USD":543814000.0,"CommonStockSharesOutstanding_0_FY_shares":36120000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":104648000.0,"NetIncomeLoss_4_FY_USD":99937000.0,"NetIncomeLoss_1_FY_USD":4306000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":33427000.0,"StockholdersEquity_0_FY_USD":508848000.0,"EarningsPerShareBasic_4_FY_USD":2.99,"EarningsPerShareBasic_1_FY_USD":0.12,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190227"}]